Dr. Corrado Tamburino, principal investigator for the ATLANTA study, stated, "I perform many angioplasties each day, and I am impressed by the performance of this stent in a very complex patient population. No thrombosis. Low binary restenosis. No MIs." The CATANIA(TM) Stent System with NanoThin Polyzene(R)-F has completed CE marking and is available for sale anywhere the CE mark is accepted.

«« US Healthcare Spending to Soar, Say Government Officials


Siemens Japan Acquires Majority Stake of Mochida Siemens Medical Systems »»


Latest Articles

Dr. Corrado Tamburino, principal investigator for the ATLANTA study, stated, "I perform many angioplasties each day, and I am impressed by the performanc...